Rchr
J-GLOBAL ID：201301042038177236   Update date: Jan. 30, 2024

ISHII YASUYUKI

イシイ ヤスユキ | ISHII YASUYUKI
Affiliation and department：
Juntendo University Faculty of Medicine

About Juntendo University Faculty of Medicine


Research field  (1)： Immunology
Research theme for competitive and other funds  (3)：
  • 2017 - 2019 A novel approach inducing transplant tolerance through NKT cell activation in combination with T cell transfer
  • 2015 - 2017 Control of Human NKT cell Responses by Immunoregulatory Liposomes and Anti- CD40 Antibody
  • 2003 - 2003 感染応答宿主防御因子チオレドキシンのプロテオーム解析による感染炎症制御機構の研究
Papers (68)：
  • Shohei Yoshida, Shigeru Miyagawa, Takashi Matsuzaki, Yasuyuki Ishii, Emi Fukuda-Kawaguchi, Takuji Kawamura, Ai Kawamura, Yuki Nakamura, Koichi Toda, Yoshiki Sawa. Chimerism through the activation of invariant natural killer T cells prolongs graft survival after transplantation of induced pluripotent stem cell-derived allogeneic cardiomyocytes. PLOS ONE. 2022. 17. 3. e0264317-e0264317
  • Makoto Nakamura, Yusuke Meguri, Shuntaro Ikegawa, Takumi Kondo, Yuichi Sumii, Takuya Fukumi, Miki Iwamoto, Yasuhisa Sando, Hiroyuki Sugiura, Noboru Asada, et al. Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression. Scientific Reports. 2021. 11. 1. 13125-13125
  • Hiroyuki Sugiura, Ken-ichi Matsuoka, Takuya Fukumi, Yuichi Sumii, Takumi Kondo, Shuntaro Ikegawa, Yusuke Meguri, Miki Iwamoto, Yasuhisa Sando, Makoto Nakamura, et al. Donor Treg expansion by liposomal α-galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft-versus-host disease. Immunity, Inflammation and Disease. 2021. 9. 3. 721-733
  • 山川 貴史, 神澤 太一, 石井 瑠美, 雑賀 寛, 石井 保之, 奥見 雅由, 横尾 隆, 田邉 一成. α-ガラクトシルセラミドとラパマイシンの併用による移植免疫寛容誘導の検証. 日本腎臓学会誌. 2020. 62. 4. 360-360
  • Takashi Kanamori, Tomoki Numata, Satoshi Kuwabara, Yasuyuki Ishii, Hiroshi Watarai, Hideya Yuasa. Photo effect on the CD1d-binding ability of azobenzene-attached analogues of α-GalCer. Bioorganic & medicinal chemistry letters. 2020. 30. 5. 126960-126960
ｍore...
MISC (123)：
  • 勝俣 陽貴, 池宮城 雅子, 石井 保之, 奥見 雅由, 田邉 一成, 横尾 隆. マウス胸腺細胞における不変ナチュラルキラーT細胞活性化を介した前駆制御性T細胞の誘導. 日本腎臓学会誌. 2019. 61. 3. 325-325
  • H. Katsumata, M. Ikemiyagi, S. Miyairi, R. Ishii, T. Kanzawa, H. Fukuda, T. Hirai, M. Okumi, Y. Ishii, K. Tanabe. A Novel Method for iNKT Cell-Mediated Ex Vivo Treg Expansion Applied to Induce Human Transplant Tolerance. AMERICAN JOURNAL OF TRANSPLANTATION. 2017. 17. 711-711
  • H. Fukuda, T. Hiai, R. Ishii, H. Katsumata, T. Kanzawa, S. Miyairi, M. Ikemiyagi, Y. Ishii, M. Okumi, K. Tanabe. CD40/CD40 Ligand Signal Controls Cytotoxic Ability of Natural Killer Cells After Invariant Natural Killer T Cell Stimulation. AMERICAN JOURNAL OF TRANSPLANTATION. 2017. 17. 654-654
  • R. Ishii, T. Hirai, Y. Ishii, M. Okumi, K. Tanabe. iNKT Cell Activation Plus Veto Cell Transfer Yields Complete Chimerism in a Murine Sub-Lethal Bone Marrow Transplant Model. AMERICAN JOURNAL OF TRANSPLANTATION. 2017. 17. 423-423
  • T. Kanzawa, T. Hirai, R. Ishii, M. Okumi, H. Ishida, Y. Ishii, K. Tanabe. Combination Therapy of iNKT Cell Ligand and CD40-CD154 Signal Blockade Establishes Islet Allograft Tolerance in Non-Myeloablative Bone Marrow Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION. 2017. 17. 702-702
ｍore...
Patents (24)：
ｍore...
Books (1)：
  • 花粉症のワクチンをつくる! (岩波科学ライブラリー)
    岩波書店 2010 ISBN:4000295675
Education (2)：
  • 1986 - 1988 Tokyo Institute of Technology Garudate school Life Chemistry
  • 1982 - 1986 Tokyo Institute of Technology Faculty of Science Chemistry
Professional career (1)：
  • 理学博士 (東京工業大学)
Work history (11)：
  • 2021/07 - 現在 Accellvecs Inc CEO
  • 2021/01 - 現在 REGiMMUNE Corp Board member
  • 2018/08 - 現在 Juntendo University Immune Diagnosis Lecturer (Part-time)
  • 2016/07 - 2020/12 REGiMMUNE Corp Executive Chairman
  • 2014/07 - 2016/06 REGiMMUNE Corp CEO
Show all
Awards (1)：
  • 2013/03 - バイオビジネス・アワード 審査員特別賞
Association Membership(s) (4)：
THE JAPANESE SOCIETY FOR IMMUNOLOGY ,  JAPANESE SOCIETY OF ALLERGOLOGY ,  The American Association of Immunologists ,  American Society of Hematology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM